53 reports of this reaction
1.6% of all TIOCONAZOLE reports
#11 most reported adverse reaction
HYPERSENSITIVITY is the #11 most commonly reported adverse reaction for TIOCONAZOLE, manufactured by Insight Pharmaceuticals LLC. There are 53 FDA adverse event reports linking TIOCONAZOLE to HYPERSENSITIVITY. This represents approximately 1.6% of all 3,387 adverse event reports for this drug.
Patients taking TIOCONAZOLE who experience hypersensitivity should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPERSENSITIVITY is a less commonly reported adverse event for TIOCONAZOLE, but still significant enough to appear in the safety profile.
In addition to hypersensitivity, the following adverse reactions have been reported for TIOCONAZOLE:
The following drugs have also been linked to hypersensitivity in FDA adverse event reports:
HYPERSENSITIVITY has been reported as an adverse event in 53 FDA reports for TIOCONAZOLE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPERSENSITIVITY accounts for approximately 1.6% of all adverse event reports for TIOCONAZOLE, making it a notable side effect.
If you experience hypersensitivity while taking TIOCONAZOLE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.